Mary Mosher

Array ( [id] => 5533106 [patent_doc_number] => 20090232894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Process for Stabilizing an Adjuvant Containing Vaccine Composition' [patent_app_type] => utility [patent_app_number] => 12/397140 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11089 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232894.pdf [firstpage_image] =>[orig_patent_app_number] => 12397140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7534805 [patent_doc_number] => 08048427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Subgenomic replicons of the flavivirus dengue' [patent_app_type] => utility [patent_app_number] => 12/394822 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 15746 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048427.pdf [firstpage_image] =>[orig_patent_app_number] => 12394822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114413 [patent_doc_number] => 08158418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Chimeric alphavirus replicon particles' [patent_app_type] => utility [patent_app_number] => 12/372295 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30666 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158418.pdf [firstpage_image] =>[orig_patent_app_number] => 12372295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054613 [patent_doc_number] => 20110110973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Influenza B Vaccines' [patent_app_type] => utility [patent_app_number] => 12/866064 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14552 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110973.pdf [firstpage_image] =>[orig_patent_app_number] => 12866064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473663 [patent_doc_number] => 20090246829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'SEQUENCE ANALYSIS OF THE TETRAVALENT ROTAVIRUS VACCINE' [patent_app_type] => utility [patent_app_number] => 12/365122 [patent_app_country] => US [patent_app_date] => 2009-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13667 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246829.pdf [firstpage_image] =>[orig_patent_app_number] => 12365122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615757 [patent_doc_number] => 20100003215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Culturing circular ssDNA viruses for the production of vaccines' [patent_app_type] => utility [patent_app_number] => 12/321755 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13695 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003215.pdf [firstpage_image] =>[orig_patent_app_number] => 12321755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563678 [patent_doc_number] => 20090136530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Influenza Hemagglutinin and Neuraminidase Variants' [patent_app_type] => utility [patent_app_number] => 12/354085 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27618 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136530.pdf [firstpage_image] =>[orig_patent_app_number] => 12354085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585043 [patent_doc_number] => 20090104245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'BIODEGRADABLE CARRIER AND METHOD FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/343030 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2821 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104245.pdf [firstpage_image] =>[orig_patent_app_number] => 12343030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264508 [patent_doc_number] => 20090117193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Compositions Comprising an Active Agent' [patent_app_type] => utility [patent_app_number] => 12/343365 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14772 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117193.pdf [firstpage_image] =>[orig_patent_app_number] => 12343365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479950 [patent_doc_number] => 20100092508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Molecular Antigen Arrays' [patent_app_type] => utility [patent_app_number] => 12/341763 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 40480 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092508.pdf [firstpage_image] =>[orig_patent_app_number] => 12341763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569383 [patent_doc_number] => 20090252761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Papilloma virus vaccine' [patent_app_type] => utility [patent_app_number] => 12/318138 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10990 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252761.pdf [firstpage_image] =>[orig_patent_app_number] => 12318138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422019 [patent_doc_number] => 20090148474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME ISOLATES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/332127 [patent_app_country] => US [patent_app_date] => 2008-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12956 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148474.pdf [firstpage_image] =>[orig_patent_app_number] => 12332127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6485223 [patent_doc_number] => 20100285445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'CHIMERIC CONSTRUCT OF MUNGBEAN YELLOW MOSAIC INDIA VIRUS (MYMIV) AND ITS USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/746429 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6054 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285445.pdf [firstpage_image] =>[orig_patent_app_number] => 12746429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6382701 [patent_doc_number] => 20100316989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'METHOD FOR SCREENING AN INHIBITORY AGENT OF HBV PROLIFERATION BY USING THE INTERACTION BETWEEN HBV CAPSID AND SURFACE PROTEINS BASED ON CELLULAR IMAGING' [patent_app_type] => utility [patent_app_number] => 12/443740 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3956 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316989.pdf [firstpage_image] =>[orig_patent_app_number] => 12443740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007018 [patent_doc_number] => 20110059049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'POXVIRAL ONCOLYTIC VECTORS' [patent_app_type] => utility [patent_app_number] => 12/743407 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12481 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059049.pdf [firstpage_image] =>[orig_patent_app_number] => 12743407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070098 [patent_doc_number] => 20110044948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'POXVIRAL ONCOLYTIC VECTORS' [patent_app_type] => utility [patent_app_number] => 12/743412 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10851 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044948.pdf [firstpage_image] =>[orig_patent_app_number] => 12743412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618774 [patent_doc_number] => 07998488 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Vaccine formulations and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/271522 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5421 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998488.pdf [firstpage_image] =>[orig_patent_app_number] => 12271522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134430 [patent_doc_number] => 20110008332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Combination Therapy to Treat Persistent Viral Infections' [patent_app_type] => utility [patent_app_number] => 12/739637 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16869 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008332.pdf [firstpage_image] =>[orig_patent_app_number] => 12739637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277988 [patent_doc_number] => 20090130120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'ANTI-RSV G PROTEIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/258260 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10613 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130120.pdf [firstpage_image] =>[orig_patent_app_number] => 12258260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490025 [patent_doc_number] => 08030047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Active truncated form of the RNA polymerase of flavivirus' [patent_app_type] => utility [patent_app_number] => 12/256046 [patent_app_country] => US [patent_app_date] => 2008-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 5786 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030047.pdf [firstpage_image] =>[orig_patent_app_number] => 12256046 [rel_patent_id] =>[rel_patent_doc_number] =>)